Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for ...
Elevance Health reported stronger-than-expected results and raised its dividend as it benefited from higher premiums, ...
Q4 2024 Earnings Call Transcript January 23, 2025 Elevance Health Inc. beats earnings expectations. Reported EPS is $3.84, ...
After a dip in the wake of the release of UnitedHealth Group's Q4 2024 earnings figures, shares in the company and other ...
Shares of Elevance Health were gaining after the health insurer turned in a strong quarter and increased its quarterly ...
Elevance Health released fourth-quarter earnings that topped analyst expectations, sending its stock higher in pre-market ...
Elevance Health (ELV – Research Report) received a Buy rating and a $485.00 price target from Cantor Fitzgerald analyst Sarah James yesterday.
Elevance Health (NYSE: ELV) Q4 2024 Earnings Call Jan 23, 2025, 8:30 a.m. ET ...
Elevance Health Inc.’s stock rose 2% Thursday and boosted other health-insurance stocks after the company delivered better-than-expected earnings and forecast growth for 2025, easing investor concerns ...
In a report released today, David S Macdonald from Truist Financial reiterated a Buy rating on Elevance Health (ELV – Research Report), with a ...